Pretreatment with nafamostat mesilate, a kallikrein inhibitor, to decrease withdrawal response associated with rocuronium

Author： Kim Yoon  

Publisher： Springer Publishing Company

ISSN： 0913-8668

Source： Journal of Anesthesia, Vol.24, Iss.4, 2010-08, pp. : 549-552

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aprotinin and Nafamostat Mesilate in Liver Surgery: Effect on Blood Loss

By  

Digestive Surgery, Vol. 24, Iss. 4, 2007-07 ,pp. : 282-287

Karger

Access to resources Recommend Favorite

Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass

By Kaminishi Y.   Hiramatsu Y.   Watanabe Y.   Yoshimura Y.   Sakakibara Y.  

The Annals of Thoracic Surgery, Vol. 77, Iss. 2, 2004-02 ,pp. : 644-650

Elsevier

Access to resources Recommend Favorite

Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury

By Hagiwara Satoshi   Iwasaka Hideo   Noguchi Takayuki  

Journal of Anesthesia, Vol. 21, Iss. 2, 2007-05 ,pp. : 164-170

Springer Publishing Company

Access to resources Recommend Favorite

Pancreatic Injuries in Rats with Fecal Peritonitis: Protective Effect of a New Synthetic Protease Inhibitor, Sepinostat Mesilate (FUT-187)

By Hirano T.  

Journal of Surgical Research, Vol. 61, Iss. 2, 1996-03 ,pp. : 301-306

Academic Press

Access to resources Recommend Favorite

Urolithiasis associated with the protease inhibitor indinavir

By Bruce R.G.   Munch L.C.   Hoven A.D.   Jerauld R.S.   Greenburg R.   Porter W.H.   Rutter P.W.  

Urology, Vol. 50, Iss. 4, 1997-10 ,pp. : 513-518

Elsevier

Access to resources Recommend Favorite